The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
David Bernstein: Managing Risk Factors in Hepatitis C
Now that most forms of hepatitis C are treatable if not curable other conditions like fatty liver disease are drawing a lot of attention in the field of hepatology. While doctors make this change in direction there is still work being done to manage risk factors in patients at risk of contracting the disease.
David Nash: Helping Doctors Transition to Population Health
For many veteran doctors there may be a leaning toward staying the course that has guided them through their careers. As times change there have been signs that doctors must also adapt to the changing medical landscape.
David Nash from Thomas Jefferson University: An Introduction to Population Health at the ACC
At the American College of Cardiology's annual meeting in Chicago the opening discussion in front of thousands of the top doctors across the country focused on a developing specialty aimed at improving patient health in non-traditional ways.
Diverticulitis: Why Operate Early?
July 26th 2016It has become increasingly common for patients having experienced as few as three episodes of diverticulitis to opt for colectomy. A study examines the efficacy of younger, less frequent sufferers receiving the surgery earlier than guidelines typically recommend.
European Regulators Update Hepatitis C Clinical Trial Guideline
July 21st 2016Recent advances in the field of hepatitis C therapy has prompted the European Medicines Agency to update its guideline for designing clinical trials on investigational direct-acting antiviral drugs that target chronic infection of the virus.